Skip to main content
. 2022 Mar 1;15:1421–1436. doi: 10.2147/JIR.S345517

Figure 1.

Figure 1

Characterization of iMSC and iMSC-sEVs. (A) Surface antigen profile of iMSC evaluated by flow cytometry. (B) Western blotting showing the expression of exosomal markers including CD9, TSG101, and CD63 in iMSC-sEVs, but not the negative marker GM130. (C) Representative image of iMSC-sEVs observed by TEM. Scale bar = 100 nm. (D) Particle size distribution of iMSC-sEVs measured by nano-flow cytometer.